BioMarin to Host Third-Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, November 1, at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical to host conference call and webcast to discuss third-quarter 2023 financial results

SAN RAFAEL, Calif., Oct. 17, 2023  /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, November 1, at 4:30 p.m. ET to discuss third-quarter 2023 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 888-330-3073
International Dial-in Number: 646-960-0683
Conference Call ID: 1816377

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 647-362-9199
Playback ID: 1816377

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2023-financial-results-conference-call-and-webcast-on-wednesday-november-1-at-430pm-et-301958470.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is the conference call and webcast scheduled?

The conference call and webcast are scheduled for Wednesday, November 1, at 4:30 p.m. ET.

Who will be hosting the conference call and webcast?

Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will be hosting the conference call and webcast.

What will be discussed during the conference call and webcast?

The conference call and webcast will cover the third-quarter 2023 financial results and provide a general business update.

How can interested parties access the conference call?

Interested parties can access a live audio webcast of the conference call via the investor section of the BioMarin website.

Will there be a replay of the conference call available?

Yes, a replay of the call will be archived on the BioMarin website for one week following the call.